Eterna Therapeutics
ERNA
#10531
Rank
โ‚น0.53 B
Marketcap
โ‚น18.21
Share price
-5.34%
Change (1 day)
-93.29%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น7,161. In 2022 the company made an earnings per share (EPS) of -โ‚น11,749 an increase over its 2021 EPS that were of -โ‚น77,620.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น11,749-84.86%
2021-โ‚น77,620

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น192.79-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น172.71-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น188.58-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น11.20-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น115.76-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น48.54-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA